Ryan Fukushima | Reinventing diagnostics: The superpower of not knowing what can’t be done | TPM #43
Talking Precision Medicine
Innovating Drug Development with AI
This chapter explores the integration of AI algorithms with medical guidelines to improve decision-making in oncology, particularly through a novel biotech company's strategies. It addresses the challenges of early clinical trials and the importance of optimizing patient selection to enhance success rates for drug development in niche cancer markets. The conversation emphasizes the need for innovative therapies and collaboration within the industry to address high unmet medical needs and improve patient outcomes.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
